Ro 363

Ro 363, an effective inotropic stimulant, is a potent and highly selective β1-adrenoceptor agonist. RO 363 is a cardiovascular modulator that reduces diastolic blood pressure and pronounces increases in myocardial contractility[1][2][3].

Product Specifications

CAS Number

[74513-77-2]

UNSPSC

12352005

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/ro-363.html

Solubility

10 mM in DMSO

Smiles

OC1=CC=C(C=C1O)OCC(CNCCC2=CC=C(C(OC)=C2)OC)O

Molecular Formula

C19H25NO6

Molecular Weight

363.40

References & Citations

[1]Maccarrone C, et al. Comparison of the Arrhythmogenic Actions of (-) -Isoprenaline, Dobutamine and the selective beta 1-adrenoceptor agonist, (+/-) - (1-[3',4'-dihydroxyphenoxy] -2-hydroxy-[3",4"-dimethoxy phenethylamino]-propane) -oxalate (Ro 363) . Arzneimittelforschung. 1985;35 (3) :592-8.|[2]Iakovidis D, et al. In vitro activity of RO363, a beta1-adrenoceptor selective agonist. Br J Pharmacol. 1980 Apr;68 (4) :677-85.|[3]Einstein R, et al. Comparison of the cardiac effects of beta-adrenoreceptor agonists in anaesthetised and conscious dogs. J Auton Pharmacol. 1986 Mar;6 (1) :9-14.